Skip to main content

Mubadala — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

102
Companies
$17.2B
Total invested
$307.9M
Avg. check
53
Industries
Medical 6Software 6Health Care 6Biotechnology 5Information Technology 5FinTech 4+47 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 102
Light Horse Therapeutics
January 2025

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology · San Diego$62.0M Series A
Tenvie Therapeutics
January 2025

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

Biotechnology · South San Francisco$200.0M Series A
HiveMQ
January 2025

HiveMQ is the proven enterprise MQTT platform designed to connect, communicate, and control IoT data under real-world stress.

Enterprise Software · LandshutVenture - Series Unknown
nChroma Bio
December 2024

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

Biotechnology · Boston$75.0M Venture - Series Unknown
Zelis
December 2024

Zelis is modernizing the healthcare financial experience for all.

Finance · BedminsterPrivate Equity
Huboo
November 2024

Huboo is an eCommerce fulfilment partner using great people and smart technology to enable businesses to grow.

E-Commerce · Bristol$58.3M Undisclosed
Firstvet
June 2024

FirstVet is a digital veterinary platform that provides video consultation services for pet owners.

Medical · Stockholm$21.5M Series C
re:cap
June 2024

re:cap is the Capital OS that seamlessly integrates debt funding, liquidity management, financial operations in one platform.

Financial Services · Berlin$14.5M Series A
Arbol
April 2024

Arbol is a climate risk coverage company that offers solutions to analyze .and mitigate exposure to climate risk.

Agriculture · New York$60.0M Series B
Andalusia Labs
December 2023

Andalusia Labs is building foundational digital infrastructure, optimized for internet markets.

Blockchain · San Francisco$48.0M Series A
Centenara Labs
September 2023

Centenara Labs is an integrated biotechnology platform company that invests in people and ideas to develop therapies.

Biotechnology · SchlierenDebt Financing
TreasurySpring
June 2023

TreasurySpring is a b2b fintech that enables clients to minimise risk and maximise return on excess cash through a unique platform.

Banking · LondonSecondary Market
Cube Highways and Infrastructure
April 2023

Cube Highways and Infrastructure, independent, professionally-managed company managing and operating a world class portfolio of toll roads.

Infrastructure · Singapore$630.0M Private Equity
Proximie
March 2023

Proximie is a health technology platform that enables surgeons to virtually attend operating theaters to visually guide complex surgeries.

Artificial Intelligence (AI) · LondonNon-equity Assistance
Virgin Orbit
February 2023

Virgin Orbit focuses on providing launch services for small satellites.

Aerospace · Long Beach$10.0M Post-IPO Equity
ACX
December 2022

Where Sustainability Meets the Global Economy

Financial Exchanges · Singapore$15.0M Convertible Note
Upstream Health
December 2022

Upstream Health provides technologies and new service approaches for health and social care teams.

Fitness · Scunthorpe$140.0M Series B
UpStream Care
December 2022

UpStream Care is the ideal marketplace solution for medicine.

Health Care · Greensboro$140.0M Series B
CERC Central de Recebíveis
October 2022

CERC is the winning platform for Financial Market Infrastructure in Brazil assembling tech-enabled solutions to foster credit access.

Financial Services · São Paulo$105.3M Venture - Series Unknown
Balbix
March 2022

Balbix offers an AI-native cyber risk and exposure management platform to give security teams a real-time view of their attack surface.

Artificial Intelligence (AI) · San Jose$70.0M Series C
Weavr
February 2022

Weavr is an online platform that creates, integrates, deploys, and runs digital payment flows.

Developer Platform · London$40.0M Series A
IXcellerate
January 2022

IXcellerate is an carrier neutral datacentre operator in Moscow that offers pure-play co-location.

Data Center · Moscow$190.0M Series C
EQRx
December 2021

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Biotechnology · Cambridge$1.2B Post-IPO Equity
Virtuoso
November 2021

Virtuoso is a software development company that develops codeless test automation software.

Information Services · London$13.3M Series A

Where Mubadala invests

Medical6
Software6
Health Care6
Biotechnology5
Information Technology5
FinTech4

About Mubadala's portfolio

How many companies has Mubadala invested in?▸

Mubadala has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Mubadala invest in?▸

Mubadala's top investment sectors include Medical, Software, Health Care, Biotechnology, Information Technology. The firm invests across 53 different industry categories.

What is Mubadala's largest investment?▸

Among tracked funding rounds, EQRx received $1.2B in a Post-IPO Equity round. Mubadala's total known invested capital is $17.2B.

What is the average investment size for Mubadala?▸

Mubadala's average investment size is $307.9M across its portfolio of 102 companies.

What are Mubadala's most recent investments?▸

Recent Mubadala portfolio additions include Light Horse Therapeutics, Tenvie Therapeutics, HiveMQ, nChroma Bio, Zelis. These companies were founded in 2020 or later.

Reach the founders behind these 102 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →